Vancomycin-resistant Staphylococcus aureus: An emerging public health threat
PATRICIA A. FLORES, PharmD
Infectious diseases pharmacy specialist, Cleveland Clinic.
STEVEN M. GORDON, MD
Hospital epidemiologist and staff physician, Department of Infectious Diseases, Cleveland Clinic.
Three reported cases of infection with strains of Staphylococcus aureus that had only intermediate susceptibility to vancomycin raise fears that high-level vancomycin resistance may soon be seen. To forestall this occurrence, physicians need to limit their use of vancomycin, and hospitals need to intensify their infection-control efforts. We review treatment options and the recommendations from the Centers for Disease Control and Prevention to identify and slow the spread of resistant strains.